Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Myriad Genetics Inc (NASDAQ:MYGN)

36.10
Delayed Data
As of Oct 16
 -0.34 / -0.93%
Today’s Change
15.15
Today|||52-Week Range
37.30
+116.56%
Year-to-Date
No recent news for Myriad Genetics Inc.

Today’s Trading

Previous close36.44
Today’s open36.84
Day’s range35.71 - 36.99
Volume596,840
Average volume (3 months)990,277
Market cap$2.5B
Dividend yield--
Data as of 10/16/2017

Growth & Valuation

Earnings growth (last year)-81.29%
Earnings growth (this year)-2.13%
Earnings growth (next 5 years)+9.25%
Revenue growth (last year)+2.33%
P/E ratio112.8
Price/Sales2.30
Price/Book3.20

Competitors

 Today’s
change
Today’s
% change
AAAPAdvanced Accelerator...+2.37+3.45%
NEOGNeogen Corp+0.50+0.65%
IMMUImmunomedics Inc-0.54-4.61%
QDELQuidel Corp-1.50-3.50%
Data as of 10/16/2017

Financials

Next reporting dateNovember 7, 2017
EPS forecast (this quarter)$0.21
Annual revenue (last year)$771.4M
Annual profit (last year)$21.8M
Net profit margin2.83%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Mark C. Capone
Executive Vice President-
International Operations
Gary A. King
Corporate headquarters
Salt Lake City, Utah

Forecasts